NOVOCURE INC. for NOVOCURE INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare Issues. H.R.5343/S.1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Foreign entity interest: Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE MEYER | Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry |
| ELLE WHITSON | Covered Official Positions Continued: Health Policy Advisor, Congresswoman Cathy McMorris Rogers; Staff Assistant / Legislative Correspondent / Legislative Assistant, Congressman Ryan Costello |
Tariff (miscellaneous tariff bills) TAR
Tariff issues, specifically related to medical device 232.
Foreign entity interest: Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE MEYER | — |
| ELLE WHITSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.